| Literature DB >> 33142939 |
Bardia Yousefi1,2, Hamed Akbari2, Xavier P V Maldague1.
Abstract
Breast cancer is the most common cancer in women. Early diagnosis improves outcome and survival, which is the cornerstone of breast cancer treatment. Thermography has been utilized as a complementary diagnostic technique in breast cancer detection. Artificial intelligence (AI) has the capacity to capture and analyze the entire concealed information in thermography. In this study, we propose a method to potentially detect the immunohistochemical response to breast cancer by finding thermal heterogeneous patterns in the targeted area. In this study for breast cancer screening 208 subjects participated and normal and abnormal (diagnosed by mammography or clinical diagnosis) conditions were analyzed. High-dimensional deep thermomic features were extracted from the ResNet-50 pre-trained model from low-rank thermal matrix approximation using sparse principal component analysis. Then, a sparse deep autoencoder designed and trained for such data decreases the dimensionality to 16 latent space thermomic features. A random forest model was used to classify the participants. The proposed method preserves thermal heterogeneity, which leads to successful classification between normal and abnormal subjects with an accuracy of 78.16% (73.3-81.07%). By non-invasively capturing a thermal map of the entire tumor, the proposed method can assist in screening and diagnosing this malignancy. These thermal signatures may preoperatively stratify the patients for personalized treatment planning and potentially monitor the patients during treatment.Entities:
Keywords: breast cancer screening; deep sparse autoencoder; deep-learning features; dimensionality reduction; imaging biomarker; vasodilator activity
Mesh:
Substances:
Year: 2020 PMID: 33142939 PMCID: PMC7693609 DOI: 10.3390/bios10110164
Source DB: PubMed Journal: Biosensors (Basel) ISSN: 2079-6374
Figure 1The block diagram of the biological connection to the response of infrared thermography as a fast step with other methods such as clinical breast exam (CBE) in breast cancer screening and cancer presence in the breast area are shown.
Figure 2Workflow of the proposed approach in temporal compression and extraction of low-rank matrix approximation and generating the deep thermomics using residual network (ResNet-50) is presented.
Figure 3The proposed sparse deep autoencoder to reduce the dimensionality of the deep-thermomics is presented.
Clinical information and demographics of the breast cancer screening database using thermal imaging.
| DMR—Database for Mastology Research | ||
|---|---|---|
|
| Median (±IQR) | 60 (25,120) |
|
| Caucasian | 77 (37%) |
| African | 57 (27.4%) | |
| Pardo | 72 (34.6%) | |
| Mulatto | 1 (0.5%) | |
| Indigenous | 1 (0.5%) | |
|
| Healthy 2 | 128 (61.5%) |
| Symptomatic (with and without cancer) | 80 (38.5%) | |
| Sick 3 | 36 (17.3%) | |
|
| Diabetes | 52 (25%) |
| Hypertensive | 5 (2.4%) | |
| Leukemia | 1 (0.5%) | |
| None | 150 (72.1%) | |
|
| Hormone replacement | 38 (18.3%) |
| None | 170 (81.7%) | |
1 This diagnosis performed with mammography as ground truth in this Dataset. 2 Healthy term is used as non-cancerous and non-symptomatic patients. 3 We use the term “sick”, which includes different types of breast cancer patients diagnosed by mammographic imaging.
Figure 4Low-rank approximation of thermal sequence determined using different Sparse PCT (principal component analysis) matrix factorization technique. Each column shows different case, columns (a–c) show symptomatic patients (diagnosed by mammography as cancer patients or healthy with symptoms), whereas columns (d–f) show the result of methods for healthy cases.
Figure 5The binary cross entropy loss is presented for training and validation of the proposed sparse autoencoder for 300 epochs.
The results of random forest classification for the cross-validated model.
| Methods | Cross-Validated Accuracy |
|---|---|
|
| 75.24 (72.33–77.67)% |
|
| 73.27 (71.84–76.21)% |
|
| 71.36 (69.42–73.3)% |
|
| 78.16 (73.3–81.07)% |
|
| 73.79 (72.33–76.7)% |
* Clinical and demographic covariates: age, and family history.
Figure 6Receiver operating characteristic (ROC) curve for different multivariate model using deep thermomic features and clinical and demographic information is presented for classifying between symptomatic and non-symptomatic participants (for baseline model).